Phase III studies to investigate survodutide for people living with obesity and overweight
Boehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...
top of page
Browse by category
Search
First patient treated with SiPore21 for sustained diabetes and obesity control
The first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...
European Medicines Agency to discuss anaesthesia risk for weight-loss drugs
The European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
ReShape Lifesciences signs license agreement with Biorad Medisys for Obalon Gastric Balloon
ReShape Lifesciences has signed an exclusive, royalty-bearing license agreement with Biorad Medysis (Biorad) to manufacture,...
ReShape strengthens patent portfolio related to its Obalon Balloon System
ReShape Lifesciences has strengthened the patent portfolio related to its Obalon Balloon System, after to US Patent and Trademark Office...
EMA grants Orphan Drug Designation for Setmelanotide for treatment of acquired hypothalamic obesity
The European Medicines Agency (EMA) has issued a positive opinion on the Rhythm Pharmaceuticals’ orphan drug designation request for...
Altimmune completes dosing in the Phase 2 MOMENTUM trial
Altimmune has completed dosing (last subject last dose) in its 48-week Phase 2 MOMENTUM trial evaluating the efficacy and safety of...
First patients treated with ECLIPSIUM hernia repair system
The first patients have been treated with Tissium's ECLIPSIUM adhesive hernia repair system and have undergone laparoscopic ventral...
Viking begins VENTURE trial of dual glp-1/gip receptor agonist VK2735 for obesity
Viking Therapeutics has initiated a Phase 2 clinical trial of VK2735, the company's wholly-owned dual agonist of the glucagon-like...
Allurion launches Coach Iris generative AI-powered weight loss coach
Allurion Technologies has launched Coach Iris, a new generative AI-powered health coach designed to enhance outcomes within the Allurion...
Browse by tag
bottom of page